Shuttle Pharmaceuticals
SHPH
2 hedge funds and large institutions have $291K invested in Shuttle Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
490% more capital invested
Capital invested by funds: $49.2K → $291K (+$241K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
33% less funds holding
Funds holding: 3 → 2 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Ayrton Capital
Westport,
Connecticut
|
+$308K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$32.7K |
| 2 |
Millennium Management
New York
|
-$14K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Ayrton Capital
Westport,
Connecticut
| $289K | +$308K | +125 | New |
|
|
FDCDDQ
2
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $2.19K | – | – | – |
|
|
3
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$32.7K | -12 | Closed |
|
|
4
Millennium Management
New York
| – | -$14K | -5 | Closed |
|
SHPH Hedge Fund Activity: Q2 2023 in Review
2 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Shuttle Pharmaceuticals (SHPH) for Q2 2023, worth a combined $291K — up 490% from $49.2K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of SHPH and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was Ayrton Capital, opening a new position worth an estimated $308K. The largest seller was Qube Research & Technologies (QRT), exiting entirely with an estimated $32.7K sold.
- 2 institutional investors held Shuttle Pharmaceuticals (SHPH) as of Q2 2023, down from 3 in Q1 2023.
- Funds reported $291K of Shuttle Pharmaceuticals stock for Q2 2023, up 490% quarter-over-quarter.
- 1 fund opened new Shuttle Pharmaceuticals positions in Q2 2023 and 2 closed out, a net change of -1 holder.
- The largest Shuttle Pharmaceuticals buyer in Q2 2023 was Ayrton Capital, an estimated $308K added.
- The largest Shuttle Pharmaceuticals seller in Q2 2023 was Qube Research & Technologies (QRT), an estimated $32.7K sold.
Based on aggregated 13F filings for Q2 2023.